Results

Total Results: 76 records

Showing results for "harm".

41. CDS Connect Implementation Guide Draft (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
    October 01, 2017 - CDS Connect Implementation Guide Draft Agency for Healthcare Research and Quality (AHRQ) Agency for Healthcare Research and Quality (AHRQ) Implementation Guide Longitudinal ASCVD Risk Assessment Tool for Shared Decision Making Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Hu…

42. Implementation Guide: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/26/2024_CDS_Connect_IG_Aspirin_Therapy.pdf
    January 01, 2024 - Implementation Guide: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication Implementation Guide US Preventive Services Task Force Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov …

43. CDS Connect Implementation Guide Draft (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM_Final.docx
    October 01, 2017 - In most cases, the potential benefit versus harm of initiating a statin must be closely considered for

44. CDS Connect Final Report Year 2 (pdf file)
    cds.ahrq.gov/sites/default/files/reports/AHRQ_Final_Report_2018.pdf
    January 01, 2018 - management summary) • An alert and/or order set to consider naloxone if risk factors for opioid-related harm … active or recurring status, onset date, asserted date, abatement date) Risk factors for opioid-related harm

45. Implementation Guide: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/26/2023_CDS_Connect_IG_Aspirin_Therapy.pdf
    January 01, 2023 - Implementation Guide: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication Implementation Guide USPSTF Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 75FCMC18D0047…

46. CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Shared Decision Making (2021) (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/76/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making.pdf
    April 01, 2021 - CMS's Million Hearts Model Longitudinal ASCVD Risk Assessment Tool for Shared Decision Making (2021) 1 Implementation Guide CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Shared Decision Making Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 www.ah…

47. Pain Management Resources to Support Clinical Decision Support Artifact Development: An Environmental Scan (pdf file)
    cds.ahrq.gov/sites/default/files/reports/CDS_Connect_Pain_Management_Environmental_Scan.pdf
    December 01, 2017 - Pain Management Resources to Support Clinical Decision Support Artifact Development: An Environmental Scan Pain Management Resources to Support Clinical Decision Support Artifact Development: An Environmental Scan CDS Connect Pain Management Resources to Support Clinical Decision Support Artifact Developmen…

48. Implementation Guide: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease (CVD): An Electronic Clinical Quality Measure (eCQM)-derived CDS (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/21/2024_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
    January 01, 2024 - In most cases, the potential benefit versus harm of initiating a statin must be closely considered for

49. Statin Therapy for the Prevention and Treatment of Cardiovascular Disease Electronic Clinical Quality Measure (April 2021) (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation%20Guide_Statin%20Therapy%20for%20the%20Prevention%20and%20Treatment%20of%20CVD%20eCQM%20Artifact.pdf
    April 01, 2021 - In most cases, the potential benefit versus harm of initiating a statin must be closely considered

50. Implementation Guide: Statin Therapy for the Prevention and Treatment of CVD: An eCQM-derived CDS (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation_Guide_Statin_Therapy_CVD_eCQM_0.pdf
    September 01, 2022 - In most cases, the potential benefit versus harm of initiating a statin must be closely considered for

51. Implementation Guide: Statin Therapy for the Prevention and Treatment of CVD: An eCQM-derived CDS (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/21/Implementation_Guide_Statin_Therapy_CVD_eCQM.pdf
    September 01, 2022 - In most cases, the potential benefit versus harm of initiating a statin must be closely considered for

52. Implementation Guide: Statin Therapy for the Prevention and Treatment of CVD: An Electronic eCQM-Derived CDS (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/21/2023_CDS_Connect_IG_Statin_Therapy_CVD_eCQM.pdf
    January 01, 2023 - In most cases, the potential benefit versus harm of initiating a statin must be closely considered for

53. Pain Management Summary Clincial Decision Support Toolkit For Repository (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository.xlsx
    January 01, 2003 - member enters> Hover text displays: "Factor that may place the patient at risk for an opioid-related harm

54. Pain Management Summary Clincial Decision Support Toolkit For Repository 0 (xls file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
    January 01, 2003 - member enters> Hover text displays: "Factor that may place the patient at risk for an opioid-related harm

55. CAMH_Template_Long_Instructions (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax_Post_Exposure_Prophylaxis_CDS_Validation_Report.pdf
    October 17, 2018 - CAMH_Template_Long_Instructions Prepared for: Centers for Disease Control and Prevention CMS Alliance to Modernize Healthcare Federally Funded Research and Development Center Anthrax Clinical Decision Support Project Task Order No. 200-2016-F-89363 Adapting Emergency Preparedness and Response Guidelines t…

56. Implementation Guide: Prediabetes and Type 2 Diabetes: Part Two, Counseling (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdf
    January 01, 2024 - results may not only decrease a patient’s trust in the information presented to them but may also cause harm

57. Implementation Guide: Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults with Cardiovascular Risk Factors (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1071/2024_CDS_Connect_IG_Healthy_Diet_Physical_Activity.pdf
    January 01, 2024 - results may not only decrease a patient’s trust in the information presented to them but may also cause harm

58. Implementation Guide: Prediabetes and Type 2 Diabetes: Part One, Screening (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_CDS_Connect_IG_Diabetes_Part_One_Screening_0.pdf
    January 01, 2024 - results may not only decrease a patient’s trust in the information presented to them but may also cause harm

59. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
    January 01, 2024 - results may not only decrease a patient’s trust in the information presented to them but also may cause harm

60. Implementation Guide: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part One, Screening (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/Implementation%20Guide_Abnormal%20Blood%20Glucose%20and%20Type%202%20DM_Part%20One,%20Screening_Final.pdf
    September 01, 2019 - results may not only decrease a patient’s trust in the information presented to them but may also cause harm